ImmuPharma's stock dropped 11.6%, trading at GBX 2.57 with a market cap of £10.27 million.
ImmuPharma's stock fell 11.6% on Wednesday, trading at GBX 2.57 ($0.03), with about 6.52 million shares exchanged. The company, which focuses on developing peptide-based drugs for autoimmune diseases and anti-infectives, saw its market cap drop to £10.27 million. The 50-day moving average is GBX 3.87, and the 200-day moving average is GBX 2.49.
4 days ago
4 Articles
You have 13 free stories remaining this month. Subscribe anytime for unlimited access.